References
Burks EJ, Loughran TP Jr (2006) Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 20:245–266
Saitoh T, Karasawa M, Sakuraya M, Norio N, Junko T, Shirakawa K, Matsushima T, Tsukamoto N, Nojima Y, Murakami H (2000) Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity. Eur J Haematol 65:272–275
Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Clin Exp Dermatol 30:61–63
Lee YJ, Kang SW, Park JJ, Bae YD, Lee EY, Lee EB, Song YW (2006) Interleukin-18 promoter polymorphisms in patients with Behcet's disease. Hum Immunol 67:812–818
Ahn JK, Chung H, Lee DS, Yu YS, Yu HG (2005) CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis. J Immunol 175:6133–6142
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saitoh, T., Matsushima, T., Kaneko, Y. et al. T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL. Ann Hematol 87, 585–586 (2008). https://doi.org/10.1007/s00277-008-0438-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0438-3